Thursday, March 23, 2023 | Back issues
Courthouse News Service Courthouse News Service

Prescription drugs

SAN FRANCISCO — The Ninth Circuit upheld a ruling against a woman who claimed Otsuka America Pharmaceutical’s antipsychotic drug Abilify caused her to develop tardive dyskinesia. The court ruled the woman did not prove the company failed to warn of a known or scientifically knowable risk at the time the drug was distributed.

Read the opinion here.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.